Skip to main content

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Aravive, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ARAV: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5949−10
Shares6.49M5.91M−584.0K (−9.0%)
Value$42.8M$35.3M−$7.44M (−17.4%)

New holders (9)

Institutions that held Aravive, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ARAV in Q2 2021
InstitutionSharesValue% of portfolio
Tibra Equities Europe Ltd56,200$336.0K0.10%
Ergoteles LLC55,600$332.0K0.01%
QS Investors, LLC37,800$227.0K0.00%
Federated Hermes, Inc.34,609$207.0K0.00%
Susquehanna International Group, LLP32,896$197.0K0.00%
Walleye Capital LLC31,899$191.0K0.01%
HRT Financial LP29,837$178.0K0.00%
ACT Capital Management, LLC23,500$141.0K0.07%
Walleye Trading LLC10,001$60.0K0.00%

Sold out (19)

Institutions that held Aravive, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.